SIGLEC15 anticorps (AA 22-319) (Cy3)
Aperçu rapide pour SIGLEC15 anticorps (AA 22-319) (Cy3) (ABIN8037177)
Antigène
Voir toutes SIGLEC15 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 22-319
-
Fonction
- Anti-SIGLEC15 Antibody Cy3 Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human SIGLEC15 recombinant protein (Position: R22-R319).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- SIGLEC15 (Sialic Acid Binding Ig-Like Lectin 15 (SIGLEC15))
-
Autre désignation
- SIGLEC15
-
Sujet
-
Background: Predicted to be involved in regulation of actin cytoskeleton organization, regulation of bone resorption, and regulation of osteoclast development. Predicted to be located in membrane. Predicted to be part of protein-containing complex. Predicted to be active in plasma membrane.
Gene Full Name: sialic acid binding Ig like lectin 15
-
ID gène
- 284266
-
UniProt
- Q6ZMC9
Antigène
-